Record-keeping and destruction of medicinal cannabis
Companies undertaking activities with cannabis under the medicinal cannabis pilot programme and the development scheme must keep a register of purchase, sale, use, etc., cf. section 17(2) of the executive order on euphoriant substances.
On a quarterly basis, companies that cultivate cannabis must also report the harvested and used quantities of cannabis to the Danish Medicines Agency according to section 18(5) of the executive order on euphoriant substances.
Detailed information on how to keep a register of cannabis is provided in the below Danish guideline.
It applies to all companies which undertake activities with medicinal cannabis that the destruction of regulated cannabis plant components may only take place upon prior approval from the Danish Medicines Agency and under the agency's control (section 13 of the executive order on euphoriant substances). This means that for every quantity of cannabis the company wishes to destruct, the company must seek an approval for destruction from the Danish Medicines Agency.
Detailed information on the requirements for destruction, including destruction method, is provided in the below Danish guideline.